NDC 58177-293

metoprolol succinate extended-release

Metoprolol Succinate

metoprolol succinate extended-release is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Ethex Corporation. The primary component is Metoprolol Succinate.

Product ID58177-293_68235c8d-a5fa-49c8-aebd-214e6c47e410
NDC58177-293
Product TypeHuman Prescription Drug
Proprietary Namemetoprolol succinate extended-release
Generic NameMetoprolol Succinate
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2009-11-01
Marketing CategoryANDA / ANDA
Application NumberANDA077176
Labeler NameEthex Corporation
Substance NameMETOPROLOL SUCCINATE
Active Ingredient Strength24 mg/1
Pharm ClassesAdrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 58177-293-04

100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (58177-293-04)
Marketing Start Date2009-11-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 58177-293-12 [58177029312]

metoprolol succinate extended-release TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA077176
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-11-01
Inactivation Date2019-10-21

NDC 58177-293-09 [58177029309]

metoprolol succinate extended-release TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA077176
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-11-01
Inactivation Date2019-10-21

NDC 58177-293-11 [58177029311]

metoprolol succinate extended-release TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA077176
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-11-01
Inactivation Date2019-10-21

NDC 58177-293-04 [58177029304]

metoprolol succinate extended-release TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA077176
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-11-01
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
METOPROLOL SUCCINATE23.75 mg/1

Pharmacological Class

  • Adrenergic beta-Antagonists [MoA]
  • beta-Adrenergic Blocker [EPC]

NDC Crossover Matching brand name "metoprolol succinate extended-release" or generic name "Metoprolol Succinate"

NDCBrand NameGeneric Name
58177-368metoprolol succinate extended-releasemetoprolol succinate extended-release
58177-358metoprolol succinate extended-releasemetoprolol succinate extended-release
58177-369metoprolol succinate extended-releasemetoprolol succinate extended-release
58177-293metoprolol succinate extended-releasemetoprolol succinate extended-release
0378-4595Metoprolol Succinatemetoprolol succinate
0378-4596Metoprolol Succinatemetoprolol succinate
0378-4597Metoprolol Succinatemetoprolol succinate
0378-4598Metoprolol Succinatemetoprolol succinate
0527-2600METOPROLOL SUCCINATEMetoprolol succinate
0527-2601METOPROLOL SUCCINATEMetoprolol succinate
0527-2602METOPROLOL SUCCINATEMetoprolol succinate
0527-2603METOPROLOL SUCCINATEMetoprolol succinate
0615-6589METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
0615-6597METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
0615-6598METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
0615-7530METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
0615-7823Metoprolol succinateMetoprolol succinate
0615-7824Metoprolol succinateMetoprolol succinate
0615-7825Metoprolol succinateMetoprolol succinate
0615-8024METOPROLOL SUCCINATEMetoprolol succinate
0615-8025METOPROLOL SUCCINATEMetoprolol succinate
0904-6322Metoprolol succinateMetoprolol succinate
0904-6323Metoprolol succinateMetoprolol succinate
0904-6324Metoprolol succinateMetoprolol succinate
0186-1088TOPROLMetoprolol succinate
0186-1090TOPROLMetoprolol succinate
0186-1092TOPROLMetoprolol succinate
0186-1094TOPROLMetoprolol succinate
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.